FLGT
Fulgent Genetics Inc
21.50$
-0.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 73.2% | 52.9% | 36.8% | 45.7% | 50.1% | 43.4% | 21.3% | 21.7% | 40.7% | 63.9% | 62.2% | 59.4% | |
| 26.8% | 47.1% | 63.2% | 54.3% | 49.9% | 56.6% | 78.7% | 78.3% | 59.3% | 36.1% | 37.8% | 40.6% | |
| 40.8% | 46.3% | 19.5% | 22.5% | 25.9% | 20.1% | 2.7% | 2.4% | 4.7% | 14.3% | 17.2% | 16.7% | |
| 18.0% | 25.3% | 25.2% | 27.4% | 25.9% | 19.7% | 3.6% | 5.1% | 17.9% | 30.8% | 31.1% | 36.2% | |
| 104.2% | 99.4% | 58.2% | 72.5% | 73.6% | 57.9% | 9.9% | 10.5% | 30.4% | 103.7% | 63.9% | 68.8% | |
| -77.5% | -52.3% | 5.0% | -18.2% | -23.7% | -1.3% | 68.8% | 10.5% | 28.8% | -67.6% | -26.1% | -28.2% | |
| 0.0% | 0.0% | 29.5% | 0.0% | 0.0% | 6.7% | 0.1% | 0.6% | 0.2% | 0.2% | 0.1% | 0.0% | |
| -77.5% | -52.1% | -24.4% | -15.6% | -21.6% | 1.3% | 69.2% | 10.5% | 29.7% | -60.2% | -18.3% | -21.7% | |
| 257.7% | 34.8% | 5.0% | -4.1% | -5.0% | 0.1% | 17.2% | 17.6% | 6.8% | 0.4% | -2.9% | -2.6% | |
| -335.1% | -86.8% | -29.5% | -14.2% | -21.0% | 1.1% | 50.8% | 10.5% | 23.2% | -58.0% | -15.1% | -18.8% | |
| -62.1% | -46.3% | 11.4% | -8.9% | -13.6% | 5.2% | 69.5% | 10.7% | 35.2% | -51.0% | -9.5% | -14.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.